1. Spear BB, Heath-Chiozzi M, Huff J (2001) Clinical application of pharmacogenetics. Trends Mol Med 7(5):201–204
2. Personalized Medicine Coalition (2014)
http://www.personalizedmedicinecoalition.org/
. Accessed 7 Feb 2014
3. European Commission (2013) Use of ‘-omics’ technologies in the development of personalised medicine.
http://ec.europa.eu/health/files/latest_news/2013-10_personalised_medicine_en.pdf
. Accessed 20 Feb 2014
4. Food and Drug Administration (2013) Table of pharmacogenomic biomarkers in drug labels.
http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm
. Accessed 3 Oct 2013
5. Food and Drug Administration (2013) Guidance for industry clinical pharmacogenomics: premarket evaluation in early-phase clinical studies and recommendations for labeling.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM337169.pdf
. Accessed 20 Feb 2014